<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Markmap</title>
<style>
* {
  margin: 0;
  padding: 0;
}
#mindmap {
  display: block;
  width: 100vw;
  height: 100vh;
}
</style>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/style.css">
</head>
<body>
<svg id="mindmap"></svg>
<script src="https://cdn.jsdelivr.net/npm/d3@7.9.0/dist/d3.min.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-view@0.18.10/dist/browser/index.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/index.js"></script><script>(()=>{setTimeout(()=>{const{markmap:x,mm:K}=window,P=new x.Toolbar;P.attach(K);const F=P.render();F.setAttribute("style","position:absolute;bottom:20px;right:20px"),document.body.append(F)})})()</script><script>((b,L,T,D)=>{const H=b();window.mm=H.Markmap.create("svg#mindmap",(L||H.deriveOptions)(D),T)})(()=>window.markmap,null,{"content":"Ocular Trauma","children":[{"content":"Corneal Foreign Bodies and Abrasions","children":[{"content":"Corneal Foreign Bodies (FBs)","children":[{"content":"Clinical Features","children":[{"content":"Photophobia, pain, injection, lacrimation, blurred vision.","children":[],"payload":{"tag":"li","lines":"13,14"}},{"content":"History of projectile striking eye; lack of protective eyewear during risky activities.","children":[],"payload":{"tag":"li","lines":"14,15"}},{"content":"FB &#xb1; rust ring (forms within 48h) or infiltrate; &#xb1; anterior uveitis.","children":[],"payload":{"tag":"li","lines":"15,17"}}],"payload":{"tag":"h3","lines":"12,13"}},{"content":"Treatment","children":[{"content":"Corneal FBs should only be removed under slit-lamp visualization.","children":[],"payload":{"tag":"li","lines":"18,19"}},{"content":"Avoid removal under direct vision with a cotton bud.","children":[],"payload":{"tag":"li","lines":"19,20"}},{"content":"Removal steps:","children":[{"content":"Explain procedure and provide a fixation target.","children":[],"payload":{"tag":"li","lines":"21,22"}},{"content":"Instil topical anaesthetic (e.g., oxybuprocaine 0.4%).","children":[],"payload":{"tag":"li","lines":"22,23"}},{"content":"Remove FB and rust ring under slit-lamp using a 26G needle.","children":[],"payload":{"tag":"li","lines":"23,24"}}],"payload":{"tag":"li","lines":"20,24"}},{"content":"Topical antibiotic (e.g., chloramphenicol 1% ointment 4&#xd7;/d for 5d).","children":[],"payload":{"tag":"li","lines":"24,25"}},{"content":"Consider short-term cycloplegic and NSAID for comfort/AC activity.","children":[],"payload":{"tag":"li","lines":"25,26"}},{"content":"Warn patient of post-anaesthetic discomfort.","children":[],"payload":{"tag":"li","lines":"26,28"}}],"payload":{"tag":"h3","lines":"17,18"}}],"payload":{"tag":"h2","lines":"7,8"}},{"content":"Corneal Abrasions","children":[{"content":"Clinical Features","children":[{"content":"Superficial/partial-thickness corneal laceration.","children":[],"payload":{"tag":"li","lines":"33,34"}},{"content":"Differentiate from deeper lacerations using oblique illumination and Seidel&#x2019;s test.","children":[],"payload":{"tag":"li","lines":"34,35"}},{"content":"Complications:","children":[{"content":"Microbial keratitis.","children":[],"payload":{"tag":"li","lines":"36,37"}},{"content":"Recurrent erosions, especially if large, ragged, involving BM.","children":[],"payload":{"tag":"li","lines":"37,39"}}],"payload":{"tag":"li","lines":"35,39"}}],"payload":{"tag":"h3","lines":"32,33"}},{"content":"Treatment","children":[{"content":"Topical antibiotic (e.g., chloramphenicol 1% ointment 4&#xd7;/d for 3d).","children":[],"payload":{"tag":"li","lines":"40,41"}},{"content":"Treat associated infiltration as microbial keratitis.","children":[],"payload":{"tag":"li","lines":"41,42"}},{"content":"Supportive care:","children":[{"content":"Short-term topical cycloplegic and NSAIDs.","children":[],"payload":{"tag":"li","lines":"43,44"}},{"content":"Avoid patching; delays healing.","children":[],"payload":{"tag":"li","lines":"44,46"}}],"payload":{"tag":"li","lines":"42,46"}}],"payload":{"tag":"h3","lines":"39,40"}}],"payload":{"tag":"h2","lines":"28,29"}}],"payload":{"tag":"h1","lines":"5,6"}},{"content":"Hyphaema","children":[{"content":"Overview","children":[{"content":"Causes","children":[{"content":"Trauma (blunt or penetrating).","children":[],"payload":{"tag":"li","lines":"53,54"}},{"content":"Surgery (e.g., trabeculectomy, iris procedures).","children":[],"payload":{"tag":"li","lines":"54,55"}},{"content":"Spontaneous (e.g., iris/angle neovascularization, hematologic diseases, tumors, IOL erosion).","children":[],"payload":{"tag":"li","lines":"55,57"}}],"payload":{"tag":"h3","lines":"52,53"}},{"content":"Clinical Features","children":[{"content":"Erythrocytes in AC:","children":[{"content":"Microhyphaema: visible only by slit-lamp.","children":[],"payload":{"tag":"li","lines":"59,60"}},{"content":"Larger bleeds: visible layer of blood.","children":[],"payload":{"tag":"li","lines":"60,61"}}],"payload":{"tag":"li","lines":"58,61"}},{"content":"Complications:","children":[{"content":"Rebleeds.","children":[],"payload":{"tag":"li","lines":"62,63"}},{"content":"Corneal staining (esp. with &#x2191;IOP).","children":[],"payload":{"tag":"li","lines":"63,64"}},{"content":"Red cell glaucoma.","children":[],"payload":{"tag":"li","lines":"64,66"}}],"payload":{"tag":"li","lines":"61,66"}}],"payload":{"tag":"h3","lines":"57,58"}},{"content":"Treatment","children":[{"content":"Admit high-risk cases (see Box 3.4).","children":[],"payload":{"tag":"li","lines":"67,68"}},{"content":"Strict bed rest and eye protection.","children":[],"payload":{"tag":"li","lines":"68,69"}},{"content":"Avoid NSAIDs, aspirin, and warfarin if possible.","children":[],"payload":{"tag":"li","lines":"69,70"}},{"content":"Use topical steroid (e.g., dexamethasone 0.1% at least 4&#xd7;/d) and cycloplegic (e.g., atropine 1% 1&#xd7;/d).","children":[],"payload":{"tag":"li","lines":"70,72"}}],"payload":{"tag":"h3","lines":"66,67"}},{"content":"Table: Specific Features in Assessment of Hyphaema","children":[{"content":"<table data-lines=\"74,79\">\n<thead data-lines=\"74,75\">\n<tr data-lines=\"74,75\">\n<th>Category</th>\n<th>Details</th>\n</tr>\n</thead>\n<tbody data-lines=\"76,79\">\n<tr data-lines=\"76,77\">\n<td>Hx</td>\n<td>Mechanism of injury, VA changes, sickle-cell status, risk factors, medications</td>\n</tr>\n<tr data-lines=\"77,78\">\n<td>O/E</td>\n<td>Hyphaema depth/distribution, IOP, iris injury (avoid gonioscopy), fundus exam</td>\n</tr>\n<tr data-lines=\"78,79\">\n<td>Ix</td>\n<td>Sickle-cell testing, B-scan US/CT if exam is limited</td>\n</tr>\n</tbody>\n</table>","children":[],"payload":{"tag":"table","lines":"74,79"}}],"payload":{"tag":"h3","lines":"72,73"}},{"content":"Monitoring and Follow-up","children":[{"content":"Daily review for IOP and rebleed monitoring.","children":[],"payload":{"tag":"li","lines":"81,82"}},{"content":"After improvement, discharge and reduce review frequency.","children":[],"payload":{"tag":"li","lines":"82,83"}},{"content":"Resume normal activity ~2 weeks post-resolution.","children":[],"payload":{"tag":"li","lines":"83,84"}},{"content":"Perform gonioscopy &#xb1; indented ophthalmoscopy.","children":[],"payload":{"tag":"li","lines":"84,85"}},{"content":"Annual IOP checks due to risk of angle recession glaucoma.","children":[],"payload":{"tag":"li","lines":"85,87"}}],"payload":{"tag":"h3","lines":"80,81"}}],"payload":{"tag":"h2","lines":"48,49"}},{"content":"Red Cell Glaucoma","children":[{"content":"Treatment","children":[{"content":"Follow hyphaema treatment.","children":[],"payload":{"tag":"li","lines":"93,94"}},{"content":"Manage &#x2191;IOP:","children":[{"content":"Topical (&#x3b2;-blockers, &#x3b1;2-agonists, CAIs) or systemic agents (acetazolamide).","children":[],"payload":{"tag":"li","lines":"95,96"}},{"content":"Avoid CAIs in sickle-cell disease/trait.","children":[],"payload":{"tag":"li","lines":"96,97"}}],"payload":{"tag":"li","lines":"94,97"}},{"content":"If meds fail: AC paracentesis &#xb1; washout, or trabeculectomy (temporary but usually sufficient).","children":[],"payload":{"tag":"li","lines":"97,99"}}],"payload":{"tag":"h3","lines":"92,93"}},{"content":"Box: High-Risk Features of Hyphaema","children":[{"content":"Children or non-compliant patients.","children":[],"payload":{"tag":"li","lines":"100,101"}},{"content":"Rebleed.","children":[],"payload":{"tag":"li","lines":"101,102"}},{"content":"Large hyphaema (&gt;1/3).","children":[],"payload":{"tag":"li","lines":"102,103"}},{"content":"Sickle-cell disease/trait.","children":[],"payload":{"tag":"li","lines":"103,104"}},{"content":"On anticoagulants or antiplatelets.","children":[],"payload":{"tag":"li","lines":"104,105"}},{"content":"Significant concurrent injury.","children":[],"payload":{"tag":"li","lines":"105,107"}}],"payload":{"tag":"h3","lines":"99,100"}}],"payload":{"tag":"h2","lines":"87,88"}}],"payload":{"tag":"h1","lines":"46,47"}},{"content":"Laser Trauma","children":[{"content":"Background","children":[{"content":"Eye amplifies laser energy by &gt;100,000&#xd7; due to lens focusing.","children":[],"payload":{"tag":"li","lines":"110,111"}},{"content":"Laser injury reports date to 1960s; adversarial use reported from 1980s.","children":[],"payload":{"tag":"li","lines":"111,112"}},{"content":"1995 Geneva Protocol bans blinding laser weapons.","children":[],"payload":{"tag":"li","lines":"112,113"}},{"content":"Laser incidents still occur (e.g., pilots targeted).","children":[],"payload":{"tag":"li","lines":"113,115"}}],"payload":{"tag":"h2","lines":"109,110"}},{"content":"Laser Effects on Vision","children":[{"content":"Glare/Dazzle","children":[{"content":"Even low-energy laser light can impair vision temporarily.","children":[],"payload":{"tag":"li","lines":"118,119"}},{"content":"Affects people performing vision-critical tasks (e.g., pilots, drivers).","children":[],"payload":{"tag":"li","lines":"119,121"}}],"payload":{"tag":"h3","lines":"117,118"}},{"content":"Flash Blindness &amp; After-Images","children":[{"content":"Temporary visual loss from bright light exposure.","children":[],"payload":{"tag":"li","lines":"122,123"}},{"content":"After-images may persist for minutes to days, vary in color, size, intensity.","children":[],"payload":{"tag":"li","lines":"123,124"}},{"content":"Usually do not significantly affect visual acuity.","children":[],"payload":{"tag":"li","lines":"124,126"}}],"payload":{"tag":"h3","lines":"121,122"}},{"content":"Visual Loss from Damage","children":[{"content":"Anterior Segment","children":[{"content":"Photokeratitis: increases light scatter, causes transient or permanent vision reduction.","children":[],"payload":{"tag":"li","lines":"130,131"}},{"content":"High-energy exposure may cause rupture.","children":[],"payload":{"tag":"li","lines":"131,132"}},{"content":"Anterior uveitis can accompany corneal injuries.","children":[],"payload":{"tag":"li","lines":"132,134"}}],"payload":{"tag":"h4","lines":"129,130"}},{"content":"Posterior Segment","children":[{"content":"Foveal burns cause functional vision loss.","children":[],"payload":{"tag":"li","lines":"135,136"}},{"content":"Bilateral involvement possible due to wide beam diameter.","children":[],"payload":{"tag":"li","lines":"136,137"}},{"content":"Low-power foveal exposure: mild/no VA loss.","children":[],"payload":{"tag":"li","lines":"137,138"}},{"content":"High-power exposure: severe VA reduction.","children":[],"payload":{"tag":"li","lines":"138,139"}},{"content":"Retinal hemorrhage worsens outcomes via masking and photoreceptor toxicity.","children":[],"payload":{"tag":"li","lines":"139,141"}}],"payload":{"tag":"h4","lines":"134,135"}}],"payload":{"tag":"h3","lines":"126,127"}}],"payload":{"tag":"h2","lines":"115,116"}},{"content":"Prevention","children":[{"content":"Laser safety governed by international standards (wavelength, power, exposure time).","children":[],"payload":{"tag":"li","lines":"142,144"}}],"payload":{"tag":"h2","lines":"141,142"}},{"content":"Treatment","children":[{"content":"Corneal Injuries","children":[{"content":"Same as thermal burns.","children":[],"payload":{"tag":"li","lines":"147,148"}}],"payload":{"tag":"h3","lines":"146,147"}},{"content":"Retinal Injuries","children":[{"content":"No proven effective treatment.","children":[],"payload":{"tag":"li","lines":"151,152"}},{"content":"Consider vitreoretinal surgery for severe hemorrhages.","children":[],"payload":{"tag":"li","lines":"152,153"}},{"content":"Subfoveal hemorrhage: displace away from fovea using:","children":[{"content":"Intravitreal C3F8","children":[],"payload":{"tag":"li","lines":"154,155"}},{"content":"Alteplase","children":[],"payload":{"tag":"li","lines":"155,156"}},{"content":"Face-down posturing","children":[],"payload":{"tag":"li","lines":"156,158"}}],"payload":{"tag":"li","lines":"153,158"}}],"payload":{"tag":"h3","lines":"150,151"}},{"content":"Table: Laser Damage by Wavelength","children":[{"content":"<table data-lines=\"160,168\">\n<thead data-lines=\"160,161\">\n<tr data-lines=\"160,161\">\n<th>Wavelength Range</th>\n<th>Pathological Effect</th>\n</tr>\n</thead>\n<tbody data-lines=\"162,168\">\n<tr data-lines=\"162,163\">\n<td>180&#x2013;315 nm (UVB/UVC)</td>\n<td>Photokeratitis</td>\n</tr>\n<tr data-lines=\"163,164\">\n<td>315&#x2013;400 nm (UVA)</td>\n<td>Photochemical cataract</td>\n</tr>\n<tr data-lines=\"164,165\">\n<td>400&#x2013;780 nm (Visible)</td>\n<td>Retinal burn</td>\n</tr>\n<tr data-lines=\"165,166\">\n<td>780&#x2013;1400 nm (NIR)</td>\n<td>Cataract, retinal burn</td>\n</tr>\n<tr data-lines=\"166,167\">\n<td>1.4&#x2013;3.0 &#x3bc;m (IR)</td>\n<td>Aqueous flare, cataract, corneal burn</td>\n</tr>\n<tr data-lines=\"167,168\">\n<td>3.0 &#x3bc;m&#x2013;1 mm</td>\n<td>Corneal burn</td>\n</tr>\n</tbody>\n</table>","children":[],"payload":{"tag":"table","lines":"160,168"}}],"payload":{"tag":"h3","lines":"158,159"}}],"payload":{"tag":"h2","lines":"144,145"}}],"payload":{"tag":"h1","lines":"107,108"}}]},null)</script>
</body>
</html>
